The Fort Worth Press - Federal Cannabis Is About to Get Receipts, SMX Prints Them at the Molecular Level

USD -
AED 3.672499
AFN 63.000218
ALL 81.288631
AMD 374.006028
ANG 1.789884
AOA 917.999815
ARS 1374.796916
AUD 1.39804
AWG 1.8025
AZN 1.701218
BAM 1.665113
BBD 2.01512
BDT 122.759818
BGN 1.668102
BHD 0.377275
BIF 2975.105995
BMD 1
BND 1.273476
BOB 6.913109
BRL 4.972103
BSD 1.000451
BTN 93.790972
BWP 13.451617
BYN 2.814964
BYR 19600
BZD 2.012209
CAD 1.366565
CDF 2313.999771
CHF 0.781895
CLF 0.022674
CLP 892.37015
CNY 6.82165
CNH 6.82785
COP 3587.3
CRC 455.822507
CUC 1
CUP 26.5
CVE 93.876908
CZK 20.751028
DJF 178.157299
DKK 6.369515
DOP 60.208755
DZD 132.379122
EGP 51.988604
ERN 15
ETB 157.484803
EUR 0.85227
FJD 2.194496
FKP 0.740159
GBP 0.740655
GEL 2.690045
GGP 0.740159
GHS 11.075448
GIP 0.740159
GMD 73.502853
GNF 8781.085844
GTQ 7.646989
GYD 209.3344
HKD 7.831984
HNL 26.580678
HRK 6.419903
HTG 130.965962
HUF 311.528025
IDR 17199
ILS 3.00095
IMP 0.740159
INR 93.75325
IQD 1310.596128
IRR 1320999.99996
ISK 122.559701
JEP 0.740159
JMD 158.492044
JOD 0.708983
JPY 159.216012
KES 129.179789
KGS 87.427398
KHR 4004.835771
KMF 419.999715
KPW 899.990254
KRW 1478.359427
KWD 0.30819
KYD 0.833745
KZT 463.595498
LAK 22073.421989
LBP 89593.471709
LKR 317.917894
LRD 184.091335
LSL 16.446219
LTL 2.95274
LVL 0.60489
LYD 6.326571
MAD 9.238104
MDL 17.138041
MGA 4149.568356
MKD 52.526174
MMK 2099.66818
MNT 3578.517246
MOP 8.0708
MRU 39.939723
MUR 46.519756
MVR 15.459805
MWK 1734.492329
MXN 17.31875
MYR 3.952499
MZN 63.901353
NAD 16.446219
NGN 1348.72979
NIO 36.821672
NOK 9.29944
NPR 150.065555
NZD 1.693155
OMR 0.384483
PAB 1.000528
PEN 3.43825
PGK 4.400759
PHP 60.163499
PKR 278.910249
PLN 3.619405
PYG 6293.366934
QAR 3.647718
RON 4.341401
RSD 100.058034
RUB 75.017642
RWF 1461.969385
SAR 3.75032
SBD 8.038772
SCR 14.260087
SDG 599.999782
SEK 9.18375
SGD 1.273735
SHP 0.746601
SLE 24.593572
SLL 20969.496166
SOS 571.778849
SRD 37.472498
STD 20697.981008
STN 20.858697
SVC 8.754693
SYP 110.631499
SZL 16.439919
THB 32.205014
TJS 9.419537
TMT 3.505
TND 2.90915
TOP 2.40776
TRY 44.92475
TTD 6.78285
TWD 31.509502
TZS 2599.999967
UAH 43.897001
UGX 3706.888478
UYU 39.776259
UZS 12134.653533
VES 481.046775
VND 26322.5
VUV 117.946979
WST 2.711482
XAF 558.460897
XAG 0.012793
XAU 0.00021
XCD 2.70255
XCG 1.803113
XDR 0.694162
XOF 558.465651
XPF 101.534165
YER 238.625022
ZAR 16.46934
ZMK 9001.200483
ZMW 19.034038
ZWL 321.999592
  • AZN

    0.2750

    196.055

    +0.14%

  • GSK

    0.0250

    56.14

    +0.04%

  • CMSD

    0.0050

    23.045

    +0.02%

  • NGG

    2.1700

    86.44

    +2.51%

  • CMSC

    -0.0700

    22.66

    -0.31%

  • BCE

    0.1810

    24.091

    +0.75%

  • JRI

    0.0960

    13.146

    +0.73%

  • RYCEF

    -1.3100

    15.85

    -8.26%

  • RBGPF

    -13.5000

    69

    -19.57%

  • RIO

    2.3200

    100.05

    +2.32%

  • BTI

    0.9000

    55.75

    +1.61%

  • BP

    0.7349

    46.635

    +1.58%

  • VOD

    0.2150

    15.405

    +1.4%

  • RELX

    0.2050

    37.28

    +0.55%

  • BCC

    0.1100

    82.505

    +0.13%

Federal Cannabis Is About to Get Receipts, SMX Prints Them at the Molecular Level
Federal Cannabis Is About to Get Receipts, SMX Prints Them at the Molecular Level

Federal Cannabis Is About to Get Receipts, SMX Prints Them at the Molecular Level

NEW YORK, NY / ACCESS Newswire / December 18, 2025 / Federal reform, if it lands as expected, is not the "green light" many traders are pricing. It is the beginning of federal-grade accountability. Recent reporting suggests President Trump may move toward reclassifying cannabis from Schedule I to Schedule III, a shift that changes the tone from cultural debate to regulatory framework.

Text size:

That matters because Schedule III is not a free pass. It is a category built around accepted medical use and a defined risk profile, with rules that are designed to reduce ambiguity, not tolerate it.

If cannabis is about to be governed more like medicine than a lifestyle product, the winners will not be the loudest brands. They will be the companies that can prove what they sell, where it came from, what happened to it, and who touched it.

The Reality of Change

Federal involvement does not remove complexity from cannabis. It formalizes it. Once cannabis enters a federal framework, documentation, chain of custody, and verification stop being optional best practices and become structural requirements.

The industry has operated for years inside a patchwork of state systems that rely heavily on declarations, labels, and after-the-fact reporting. That approach does not scale to federal oversight. Regulators do not audit marketing language. They audit systems.

Standardization is where many operators will struggle, not because they lack intent, but because their infrastructure was never designed for continuous, defensible proof.

Where Cannabis Breaks Down is Where SMX Starts

Cannabis is not a single product. It is genetics, cultivation methods, batch variation, extraction processes, formulation, testing, packaging, and distribution across jurisdictions with conflicting rules.

That complexity is precisely where traditional compliance systems fail. Labels can be swapped. Records can be reconciled later. Digital logs can look clean while physical reality diverges.

SMX (NASDAQ:SMX) was built for this exact problem. Its technology attaches food-grade molecular identity and verification at the material level, allowing products to carry a persistent truth layer as they move through the supply chain. With it, compliance no longer depends on trust or declarations. It depends on verification.

Seed-to-Sale Becomes Evidence-to-Sale

As federal standards take shape, the expectation becomes simple and unforgiving: show your work. Not in a spreadsheet after the fact, not in a marketing claim, but as a continuous, auditable record that travels with the product.

That shift favors systems that reduce friction between growers, labs, manufacturers, distributors, and regulators. When proof becomes the currency, the companies that generate it gain leverage across the entire ecosystem.

SMX is already aligned with that reality. Its platform was designed for provenance, traceability, and accountability, the very gaps exposed when an industry moves from state-level tolerance to federal guardrails.

The Winners Will Be Boring in the Right Ways

In other words, SMX is again in the right place at the right time to seize a global opportunity. Markets tend to react to cannabis reform headlines with excitement. Regulators react with checklists. Those perspectives rarely overlap.

If cannabis is reclassified, the narrative quickly shifts toward medical framing, research pathways, controlled distribution, and risk management. Hype fades. Infrastructure matters.

SMX fits that future because it does not sell stories. It sells immutable molecular-level verification. And as cannabis enters its most consequential phase yet, verification is no longer a feature. It is the business model.

About SMX

As global businesses face new and complex challenges relating to carbon neutrality and meeting new governmental and regional regulations and standards, SMX is able to offer players along the value chain access to its marking, tracking, measuring and digital platform technology to transition more successfully to a low-carbon economy.

Forward-Looking Statements

The information in this press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words "anticipate," "believe," "contemplate," "continue," "could," "estimate," "expect," "forecast," "intends," "may," "will," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this press release may include, for example: matters relating to the Company's fight against abusive and possibly illegal trading tactics against the Company's stock; successful launch and implementation of SMX's joint projects with manufacturers and other supply chain participants of steel, rubber and other materials; changes in SMX's strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans; SMX's ability to develop and launch new products and services, including its planned Plastic Cycle Token; SMX's ability to successfully and efficiently integrate future expansion plans and opportunities; SMX's ability to grow its business in a cost-effective manner; SMX's product development timeline and estimated research and development costs; the implementation, market acceptance and success of SMX's business model; developments and projections relating to SMX's competitors and industry; and SMX's approach and goals with respect to technology. These forward-looking statements are based on information available as of the date of this press release, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing views as of any subsequent date, and no obligation is undertaken to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. As a result of a number of known and unknown risks and uncertainties, actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include: the ability to maintain the listing of the Company's shares on Nasdaq; changes in applicable laws or regulations; any lingering effects of the COVID-19 pandemic on SMX's business; the ability to implement business plans, forecasts, and other expectations, and identify and realize additional opportunities; the risk of downturns and the possibility of rapid change in the highly competitive industry in which SMX operates; the risk that SMX and its current and future collaborators are unable to successfully develop and commercialize SMX's products or services, or experience significant delays in doing so; the risk that the Company may never achieve or sustain profitability; the risk that the Company will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; the risk that the Company experiences difficulties in managing its growth and expanding operations; the risk that third-party suppliers and manufacturers are not able to fully and timely meet their obligations; the risk that SMX is unable to secure or protect its intellectual property; the possibility that SMX may be adversely affected by other economic, business, and/or competitive factors; and other risks and uncertainties described in SMX's filings from time to time with the Securities and Exchange Commission.

Contact: [email protected]

SOURCE: SMX (Security Matters) Public Limited



View the original press release on ACCESS Newswire

M.McCoy--TFWP